• Genoa in the News

Genoa Healthcare® featured in Chain Drug Review’s 2022 Industry Outlook

Jan 21st, 2022

Genoa Healthcare Chief Executive Officer Joe Douglas provides outlook for 2022

2022 will be another important year for the behavioral health community. The increase in mental illness and substance use disorder, along with the staffing challenges and shift to telehealth that we saw in 2021, will continue to impact the health care industry. Our pharmacy teams are prepared to step up with additional services that meet the changing needs of our partners and consumers.

Genoa Healthcare Chief Executive Officer Joe Douglas takes a look at the opportunities for expanded access to care in 2022 and provides an industry outlook in Chain Drug Review’s 2022 forecast. You can read the full article here or view it in Chain Drug Review’s recent issue.

Recent Posts


  • Blog Post
  • Genoa in the News
Chain Drug Review features Genoa Healthcare’s efforts to increase vaccine access for medically underserved populations

When the COVID-19 vaccine became widely available last year, Genoa Healthcare® pharmacists administered immunizations to thousands of consumers across the country and demonstrated the critical role pharmacists have in providing...

  • Pharmacy Openings
Announcing six new pharmacy openings!

We’re excited to announce the opening of six pharmacies last month. We welcome all new pharmacy staff to the team and are excited to partner with these organizations to serve...

  • Pharmacy Openings
Announcing seven new pharmacy openings!

We’re excited to announce the opening of seven pharmacies last month. We welcome all new pharmacy staff to the team and are excited to partner with these organizations to serve their...

  • Blog Post
Genoa Healthcare® Pharmacists’ Trusting Consumer Relationships Aid in Support for Long-Acting Injectable Treatments

Providing Support for Long-Acting Injectable Treatments When a consumer who had recently been discharged from the hospital came into their Genoa pharmacy to receive a long-acting injectable (LAI) treatment for...